The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation
Authors:
Open Access
- 29 January 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (1) , e0148097
Abstract
High reactive oxygen species (ROS) levels and enhanced vascular smooth muscle cells (VSMC) proliferation are observed in numerous cardiovascular diseases. The mechanisms by which hormones such as angiotensin II (Ang II) acts to promote these cellular responses remain poorly understood. We have previously shown that the ADP-ribosylation factor 6 (ARF6), a molecular switch that coordinates intracellular signaling events can be activated by the Ang II receptor (AT1R). Whether this small GTP-binding protein controls the signaling events leading to ROS production and therefore Ang II-dependent VSMC proliferation, remains however unknown. Here, we demonstrate that in rat aortic VSMC, Ang II stimulation led to the subsequent activation of ARF6 and Rac1, a key regulator of NADPH oxidase activity. Using RNA interference, we showed that ARF6 is essential for ROS generation since in conditions where this GTPase was knocked down, Ang II could no longer promote superoxide anion production. In addition to regulating Rac1 activity, ARF6 also controlled expression of the NADPH oxidase 1 (Nox 1) as well as the ability of the EGFR to become transactivated. Finally, ARF6 also controlled MAPK (Erk1/2, p38 and Jnk) activation, a key pathway of VSMC proliferation. Altogether, our findings demonstrate that Ang II promotes activation of ARF6 to controls ROS production by regulating Rac1 activation and Nox1 expression. In turn, increased ROS acts to activate the MAPK pathway. These signaling events represent a new molecular mechanism by which Ang II can promote proliferation of VSMC.Keywords
This publication has 42 references indexed in Scilit:
- Role of Angiotensin II in Cardiovascular Disease — Therapeutic Implications of More Than a Century of ResearchJournal of the Renin-Angiotensin-Aldosterone System, 2006
- Reactive oxygen species and angiotensin II signaling in vascular cells: implications in cardiovascular diseaseBrazilian Journal of Medical and Biological Research, 2004
- Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategiesNature Medicine, 2002
- Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle CellsPharmacological Reviews, 2000
- Angiotensin II Receptor Coupling to Phospholipase D Is Mediated by the βγ Subunits of Heterotrimeric G Proteins in Vascular Smooth Muscle CellsMolecular Pharmacology, 1999
- Cell Cycle ProgressionCirculation, 1998
- Temporal Dispersion of Activation of Phospholipase C-β1 and -γ Isoforms by Angiotensin II in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1998
- Regulation of cell proliferation and growth by angiotensin IIProgress in Growth Factor Research, 1994
- Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.Circulation Research, 1991
- Replication of smooth muscle cells in vascular disease.Circulation Research, 1986